FI103091B1 - Menetelmä viivästyneesti vapauttavan koostumuksen valmistamiseksi - Google Patents

Menetelmä viivästyneesti vapauttavan koostumuksen valmistamiseksi

Info

Publication number
FI103091B1
FI103091B1 FI922369A FI922369A FI103091B1 FI 103091 B1 FI103091 B1 FI 103091B1 FI 922369 A FI922369 A FI 922369A FI 922369 A FI922369 A FI 922369A FI 103091 B1 FI103091 B1 FI 103091B1
Authority
FI
Finland
Prior art keywords
pct
preparing
sustained release
release composition
sec
Prior art date
Application number
FI922369A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI922369A (fi
FI922369A0 (fi
FI103091B (fi
Inventor
Stephen Gordon Ring
David Brian Archer
Michael Charles Allwood
John Michael Newton
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of FI922369A publication Critical patent/FI922369A/fi
Publication of FI922369A0 publication Critical patent/FI922369A0/fi
Application granted granted Critical
Publication of FI103091B1 publication Critical patent/FI103091B1/fi
Publication of FI103091B publication Critical patent/FI103091B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Die Bonding (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Paints Or Removers (AREA)
FI922369A 1989-11-24 1992-05-22 Menetelmä viivästyneesti vapauttavan koostumuksen valmistamiseksi FI103091B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898926639A GB8926639D0 (en) 1989-11-24 1989-11-24 Delayed release formulations
PCT/GB1990/001803 WO1991007949A1 (en) 1989-11-24 1990-11-22 Delayed release formulations

Publications (4)

Publication Number Publication Date
FI922369A FI922369A (fi) 1992-05-22
FI922369A0 FI922369A0 (fi) 1992-05-22
FI103091B1 true FI103091B1 (fi) 1999-04-30
FI103091B FI103091B (fi) 1999-04-30

Family

ID=10666886

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922369A FI103091B (fi) 1989-11-24 1992-05-22 Menetelmä viivästyneesti vapauttavan koostumuksen valmistamiseksi

Country Status (17)

Country Link
US (1) US5294448A (de)
EP (1) EP0502032B1 (de)
JP (1) JP2975680B2 (de)
KR (1) KR920703030A (de)
AT (1) ATE103174T1 (de)
CA (1) CA2069485C (de)
DE (1) DE69007623T2 (de)
DK (1) DK0502032T3 (de)
ES (1) ES2053206T3 (de)
FI (1) FI103091B (de)
GB (2) GB8926639D0 (de)
HU (1) HU209243B (de)
NO (1) NO303424B1 (de)
NZ (1) NZ236188A (de)
RU (1) RU2093148C1 (de)
WO (1) WO1991007949A1 (de)
ZA (1) ZA909384B (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3034592B2 (ja) * 1990-11-20 2000-04-17 わかもと製薬株式会社 経口用固形製剤及びその製造法
DE4120918A1 (de) * 1991-06-25 1993-01-07 Basf Ag Pulverfoermige praeparate aus einer wasserunloeslichen kernsubstanz und einer schutzhuelle
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
EP0542299B1 (de) * 1991-11-15 1999-08-04 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Esterbindung enthaltende Polymere für pharmazeutische Zubereitungen
US7070806B2 (en) 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US5565407A (en) * 1993-12-27 1996-10-15 University Of Kansas Center For Research, Inc. Biologically active agent encapsulated in biodegradable starch/polymer matrices
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
US5656294A (en) * 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
TR199801158T2 (xx) * 1995-12-21 1998-09-21 Farmaceutisk Laboratorium Ferring A/S Ba��rsak hastal�klar� i�in oral farmas�tik kompozisyon.
US6004581A (en) * 1995-12-21 1999-12-21 Farmaceutisk Laboratorium Ferring A/S Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
GB9722426D0 (en) * 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
GB9724186D0 (en) * 1997-11-14 1998-01-14 British Tech Group Low temperature coatings
AU2001253479A1 (en) * 2000-04-13 2001-10-30 Sts Biopolymers, Inc. Targeted therapeutic agent release devices and methods of making and using the same
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
FI20002768A (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
WO2002072033A2 (en) * 2001-03-13 2002-09-19 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms containing glucocorticosteroid
US7771468B2 (en) * 2001-03-16 2010-08-10 Angiotech Biocoatings Corp. Medicated stent having multi-layer polymer coating
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
AU2004273958A1 (en) * 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
CA2539051C (en) * 2003-09-19 2014-08-12 Penwest Pharmaceuticals Co. Delayed release dosage forms
EP1699442A2 (de) * 2003-12-31 2006-09-13 Genzyme Corporation Aliphatische amin-polymer-gallensäure-sequestriermittel mit magensaftresistentem überzug
EP1784166B1 (de) * 2004-09-01 2009-03-04 The Procter and Gamble Company Zusammensetzungen mit 5-amino-2-hydroxybenzoesäure und einem reduzierendem zucker
US20060165745A1 (en) * 2005-01-21 2006-07-27 Yiwen Chew Sustained release tablets for treatment of aqueous environment and methods for making the same
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
CA2683407C (en) 2007-04-04 2016-09-20 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
TWI422398B (zh) * 2007-06-04 2014-01-11 Univ London 結腸給藥配方
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
WO2010040113A1 (en) 2008-10-03 2010-04-08 Salix Pharmaceuticals, Ltd. Compositions and methods for the treatment of bowel diseases with granulated mesalamine
ES2425762T3 (es) 2008-10-27 2013-10-17 Roquette Freres Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
TWI453029B (zh) 2009-01-14 2014-09-21 Novacta Biosystems Ltd 去氧艾克特卡丁b(deoxyactagardine b), 包含其之醫藥組合物及其製造方法
BRPI1007884A2 (pt) 2009-02-04 2016-09-06 Novacta Biosystems Ltd derivados de actagardina
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
EP2386297A1 (de) * 2010-04-28 2011-11-16 Roquette Frères Unverdauliches Polymer: Filmüberzüge auf Basis von acetylierter Stärke für Colon-Targeting
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
DK3400944T3 (da) 2010-11-08 2020-10-12 Albireo Ab Ibat-inhibitorer til behandling af leversygdomme
EP2830599B1 (de) 2012-03-29 2018-08-15 Therabiome, Llc Ortsspezifische gastrointestinale orale impfrezepte zur wirkung am ileum und am blinddarm
EP2659881B1 (de) 2012-04-30 2017-11-29 Tillotts Pharma Ag Arzneimittelformulierung mit verzögerter Freisetzung
CN105120847B (zh) 2013-03-14 2018-12-28 塞拉拜姆有限责任公司 益生生物和/或治疗剂的靶向胃肠道递送
MA38847B2 (fr) 2013-10-29 2021-02-26 Tillotts Pharma Ag Formulation médicamenteuse à libération retardée
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
WO2015199147A1 (ja) 2014-06-25 2015-12-30 味の素株式会社 固形製剤及びその着色防止又は着色低減方法
BR112017009510A2 (pt) 2014-11-07 2017-12-19 Sigmoid Pharma Ltd composições compreendendo ciclosporina
DE102015000795A1 (de) * 2015-01-23 2016-07-28 Se Tylose Gmbh & Co. Kg Reversibel vernetzte Celluloseether und Verfahren zu deren Herstellung durch selektive Oxidation von vicinalen OH-Gruppen
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10786529B2 (en) * 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
EP3664781A1 (de) 2017-08-09 2020-06-17 Albireo AB Cholestyramingranulate, orale cholestyraminformulierungen und ihre verwendung
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
SG11202012151XA (en) 2018-06-20 2021-01-28 Albireo Ab Crystal modifications of odevixibat
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
EP3662902A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Formulierung mit freisetzung eines wirkstoffs im kolon
EP3662898A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Feste formulierung enthaltend mesalazin
EP3662900A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Kolonwirkstoffverabreichungsformulierung
EP3662901A1 (de) 2018-12-07 2020-06-10 Tillotts Pharma AG Arzeimittelformulierung mit verzögerter freisetzung mit einer aussenschicht enthaltend ein enzymatisch abbaubares polymer, ihre zusammensetzung und ihr herstellungsverfahren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3360633D1 (en) * 1982-02-12 1985-10-03 Unitika Ltd Anti-cancer device
US4755397A (en) * 1986-12-24 1988-07-05 National Starch And Chemical Corporation Starch based particulate encapsulation process
US4911952A (en) * 1987-07-10 1990-03-27 The United States Of America As Represented By The Secretary Of Agriculture Encapsulation by entrapment within matrix of unmodified starch
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations

Also Published As

Publication number Publication date
EP0502032B1 (de) 1994-03-23
ZA909384B (en) 1992-07-29
KR920703030A (ko) 1992-12-17
JPH05504947A (ja) 1993-07-29
FI922369A (fi) 1992-05-22
HU209243B (en) 1994-04-28
HUT62463A (en) 1993-05-28
JP2975680B2 (ja) 1999-11-10
FI922369A0 (fi) 1992-05-22
ES2053206T3 (es) 1994-07-16
DE69007623T2 (de) 1994-06-30
GB9025373D0 (en) 1991-01-09
RU2093148C1 (ru) 1997-10-20
CA2069485C (en) 2000-04-18
GB2238243A (en) 1991-05-29
ATE103174T1 (de) 1994-04-15
NO922026D0 (no) 1992-05-22
NO303424B1 (no) 1998-07-13
NZ236188A (en) 1992-11-25
GB2238243B (en) 1993-09-08
DK0502032T3 (da) 1994-05-09
EP0502032A1 (de) 1992-09-09
WO1991007949A1 (en) 1991-06-13
DE69007623D1 (de) 1994-04-28
GB8926639D0 (en) 1990-01-17
HU9201719D0 (en) 1992-08-28
NO922026L (no) 1992-07-23
US5294448A (en) 1994-03-15
FI103091B (fi) 1999-04-30

Similar Documents

Publication Publication Date Title
FI103091B1 (fi) Menetelmä viivästyneesti vapauttavan koostumuksen valmistamiseksi
BR9611175B1 (pt) compostos e composiÇÕes farmacÊuticas.
SE9502244D0 (sv) A composition and a process for the preparation thereof
NO955027D0 (no) Filmbelagt tablett av astemizol og pseudoefedrin, med forlenget frigivelse
HU76547A2 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
ES2037422T3 (es) Formulas para liberacion retardada.
FI113644B (fi) Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi
FI935732A (fi) Faramceutiska formulationer av osteogeniska proteiner
DE69123159T2 (de) Therapeutische zusammensetzung und verfahren für ihre herstellung
ATE173399T1 (de) Retardtablette mit einem gehalt an diclofenac-na
KR970702880A (ko) 신규한 펩티드 활성 물질 및 그의 제조 방법(New Peptide Active Substance And Production Thereof)
FI962301A (fi) Substituoidut aminoalkyyliaminopyridiinit
HUT70477A (en) Leukotriene-b4 derivatives, process for preparing the same and medicaments contg. them cont. the same

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ALIZYME THERAPEUTICS LIMITED

Free format text: ALIZYME THERAPEUTICS LIMITED